Haese A - Search Results

1

Posterior musculofascial reconstruction after radical prostatectomy: an updated systematic review and a meta-analysis.

Grasso AA, Mistretta FA, Sandri M, Cozzi G, De Lorenzis E, Rosso M, Albo G, Palmisano F, Mottrie A, Haese A, Graefen M, Coelho R, Patel VR, Rocco B. Grasso AA, et al. Among authors: haese a. BJU Int. 2016 Jul;118(1):20-34. doi: 10.1111/bju.13480. Epub 2016 Apr 7. BJU Int. 2016. PMID: 26991606 Review.

2

Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.

Haese A, Graefen M, Noldus J, Hammerer P, Huland E, Huland H. Haese A, et al. J Urol. 1997 Dec;158(6):2188-92. doi: 10.1016/s0022-5347(01)68192-8. J Urol. 1997. PMID: 9366341

3

Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomy.

Graefen M, Hammerer P, Michl U, Noldus J, Haese A, Henke RP, Huland E, Huland H. Graefen M, et al. Among authors: haese a. Urology. 1998 Mar;51(3):437-42. doi: 10.1016/s0090-4295(97)00608-0. Urology. 1998. PMID: 9510349

4

Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.

Haese A, Huland E, Graefen M, Hammerer P, Noldus J, Huland H. Haese A, et al. J Urol. 1999 Apr;161(4):1206-11. J Urol. 1999. PMID: 10081870 Clinical Trial.

5

Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.

Graefen M, Noldus J, Pichlmeier U, Haese A, Hammerer P, Fernandez S, Conrad S, Henke R, Huland E, Huland H. Graefen M, et al. Among authors: haese a. Eur Urol. 1999;36(1):21-30. doi: 10.1159/000019922. Eur Urol. 1999. PMID: 10364651

6

Supersensitive PSA-analysis after radical prostatectomy: a powerful tool to reduce the time gap between surgery and evidence of biochemical failure.

Haese A, Huland E, Graefen M, Huland H. Haese A, et al. Anticancer Res. 1999 Jul-Aug;19(4A):2641-4. Anticancer Res. 1999. PMID: 10470210

7

Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.

Haese A, Becker C, Noldus J, Graefen M, Huland E, Huland H, Lilja H. Haese A, et al. J Urol. 2000 May;163(5):1491-7. doi: 10.1016/s0022-5347(05)67649-5. J Urol. 2000. PMID: 10751864

8

Stage migration in clinically localized prostate cancer.

Noldus J, Graefen M, Haese A, Henke RP, Hammerer P, Huland H. Noldus J, et al. Among authors: haese a. Eur Urol. 2000 Jul;38(1):74-8. doi: 10.1159/000020255. Eur Urol. 2000. PMID: 10859445

9

[Therapeutic options in hormone refractory prostate carcinoma].

Graefen M, Hammerer P, Haese A, Huland H. Graefen M, et al. Among authors: haese a. Urologe A. 2000 May;39(3):267-73. doi: 10.1007/s001200050354. Urologe A. 2000. PMID: 10872254 Review. German. No abstract available.

10

[Mucinous adenocarcinoma of the urachus. Case report and review of the literature].

Reek C, Graefen M, Erbersdobler A, Haese A. Reek C, et al. Among authors: haese a. Urologe A. 2000 Nov;39(6):572-5. doi: 10.1007/s001200050413. Urologe A. 2000. PMID: 11138280 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters